Core Viewpoint - The announcement details the progress of the shareholding increase plan by the controlling shareholder and its concerted parties, indicating that no shares have been purchased yet despite the plan being halfway through its timeline [2][3]. Group 1: Shareholding Increase Plan - The controlling shareholder, Zhonghai Heng, and its concerted party, Guoxin Development Investment Management Co., plan to increase their shareholding in the company within six months from the announcement date, with a proposed investment amount between RMB 100 million and RMB 200 million [2]. - As of July 8, 2025, the shareholding increase plan has reached its halfway point, but no shares have been acquired yet due to the parties' internal arrangements [2][3]. - The shareholding increase will comply with relevant laws and regulations, ensuring that it does not affect the company's compliance with listing conditions or lead to changes in the controlling shareholder or actual controller [3]. Group 2: Regulatory Compliance - The shareholding increase plan adheres to the Company Law, Securities Law, and other relevant regulations, as well as the business rules of the Shenzhen Stock Exchange [2][3]. - The company will continue to monitor the progress of the shareholding increase plan and fulfill its information disclosure obligations in accordance with the Shenzhen Stock Exchange's regulations [3].
国新健康: 关于控股股东及其一致行动人增持股份计划实施进展暨增持时间过半的公告